Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines

Gut

Volumn 43, Issue 5, 1998, Pages 692-698

  Von Marschall, Z ^a   Riecken, E O ^a   Rosewicz, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Matrix metalloproteinases; Pancreatic cancer; Retinoic acid; Stromelysin 3

Indexed keywords

RETINOIC ACID; STROMELYSIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031797110     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.5.692     Document Type: Article

References (30)

1. Silverberg E, Boring CC, Squires TS. Cancer statistics 1990. Canadian Cancer Journal of Clinicians 1990;40:9-26.
2. Arbuck SG. Chemotherapy for pancreatic cancer. Baillieres Clin Gastroenterol 1990;4:953-64.
3. Bakkevold KE, Arnesjo B, Kambestag B. Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumor site. A prospective multicentre trial in 472 patients. Scand J Gastroenterol 1992;27:317-25.
4. Liotta IA, Kohn E. Cancer invasion and metastases. JAMA 1990;263:1123-6.
5. Liotta IA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
6. Chen WT. Membrane proteases: roles in tissue remodeling and tumor invasion. Curr Opin Cell Biol 1992;4:802-9.
7. Basset P, Bellocq JP, Wolf C, et al. A novel matrix metalloprotease gene specifically expressed in stromal cells of breast carcinomas. Nature 1990;348:699-704.
8. Wolf C, Rouyer N, Lutz Y, et al. Stromelysin-3 belongs to a subgroup of protemases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 1993;90:1843-7.
9. Wolf C, Chenard MP, de Grossouvre DP, et al. Breast-cancer associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing. J Invest Dermatol 1992;99:870-2.
10. Muller D, Wolf C, Abecassis J, et al. Increased stromelysin-3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas. Cancer Res 1993;53:165-9.
11. Engel G, Heselmeyer K, Auer G, et al. Correlation between stromelysin-3 mRNA concentration and outcome of human breast cancer. Int J Cancer 1994;58:830-5.
12. Rouyer N, Wolf C, Chenard MP, et al. Stromelysin-3 gene expression in human cancer: an overview. Invasion Metastasis 1994;14:269-75.
13. Pei D, Majumdar G, Weiss SJ, Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 1994;269:25849-55.
14. Pei D, Weiss SJ. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995;375:244-6.
15. Finlay TH, Tamir S, Kadner SS, et al. α1-antitrypsin- and anchorage-independent growth of MCF-7 breast cancer cells. Endocrinology 1993;133:996-1002.
16. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
17. Chirgwin JM, Przybyla AE, MacDonald RJ, et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-9.
18. Rosewicz S, Stier U, Brembeck U, et al. Retinoids: effects on growth, differentiation and nuclear receptor expression in human pancreatic carcinoma cell lines. Gastroenterology 1995;109:1646-60.
19. Rosewicz S, Detjen K, Kaiser A, et al. Bombesin receptor gene transcription in rat pancreatic acinar AR42J cells: transcriptional regulation by glucocorticoids. Gastroenterology 1994;107:208-18.
20. Nelson JA, Groudine M. Transcriptional regulation as assayed by an in vitro elongation system. Mol Cell Biol 1986;6:452-61.
21. Klöppel G. Pathology of nonendocrine tumors. In: Go VLW, DiMagno EP, Gardner JD, et al, eds. The pancreas. New York: Raven Press, 1993:871-97.
22. Rosewicz S, Wollbergs K, van Lampe B, et al. Retinoids inhibit adhesion to laminin in human pancreatic carcinoma cells via the α6 β1-integrin receptor. Gastroenterology 1997; 112:532-42.
23. Korc M, Chandresakar B, Yamaka Y, et al. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor α. J Clin Invest 1992;90:1352-60.
24. Yamaka Y, Friess H, Buchler H, et al. Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993;53:5289-96.
25. Anderson IC, Sugarbaker DJ, Ganju RK, et al. Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts. Cancer Res 1995;55:4120-6.
26. Muindi JRF, Frankel SR, Huselton C, et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. Cancer Res 1992;52:2138-42.
27. Leid M, Kastner P, Chambon P. Multiplicity generates diversity in the retinoic acid pathway. Trends Biol Sci 1992; 17:427-33.
28. Giguere V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 1994;15:61-79.
29. Pan L, Eckhoff C, Brinckerhoff CH. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs. J Cell Biochem 1995;57:575-89.
30. Nicholson R, Mader S, Nagpal S, et al. Negative regulation of the rat stromelysin gene promotor by retinoic acid is mediated by an AP1 binding site. EMBO J 1990;9:4443-54.